
Keywords: aCSF; artificial cerebrospinal fluid; AICAR; 5-aminoimidazole-4-carboxamide-riboside; AMPK; 5â² adenosine monophosphate-activated protein kinase; ARH; arcuate hypothalamic nucleus; AVPV; anteroventral periventricular nucleus; CRH; corticotropin-releasing